SILO

Silo Pharma (QB) (SILO)

Silo Pharma Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:SILO

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/30	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2023/05/27	05 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SILO	Silo Pharma Inc (QB)
2023/05/19	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SILO	Silo Pharma Inc (QB)
2023/02/16	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2023/02/15	06 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:SILO	Silo Pharma Inc (QB)
2023/02/03	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2023/02/01	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2023/01/20	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2022/12/16	06 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SILO	Silo Pharma Inc (QB)
2022/12/02	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2022/11/11	06 : 49	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SILO	Silo Pharma Inc (QB)
2022/10/19	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2022/09/30	21 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2022/09/29	05 : 35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:SILO	Silo Pharma Inc (QB)
2022/09/27	21 : 30	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	USOTC:SILO	Silo Pharma Inc (QB)
2022/09/27	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:SILO	Silo Pharma Inc (QB)
2022/09/27	05 : 01	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	USOTC:SILO	Silo Pharma Inc (QB)
2022/09/09	19 : 01	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SILO	Silo Pharma Inc (QB)
2022/08/29	19 : 17	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SILO	Silo Pharma Inc (QB)
2022/08/02	05 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SILO	Silo Pharma Inc (QB)
2022/07/25	20 : 13	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SILO	Silo Pharma Inc (QB)
2022/06/21	21 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SILO	Silo Pharma Inc (QB)
2022/05/14	05 : 19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SILO	Silo Pharma Inc (QB)
2022/03/12	06 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)
2022/03/08	07 : 26	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:SILO	Silo Pharma Inc (QB)
2022/02/15	07 : 43	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:SILO	Silo Pharma Inc (QB)
2022/01/06	08 : 19	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:SILO	Silo Pharma Inc (QB)
2021/12/16	03 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SILO	Silo Pharma Inc (QB)
2021/11/11	07 : 15	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SILO	Silo Pharma Inc (QB)
2021/10/28	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SILO	Silo Pharma Inc (QB)